Hemcheck ensures that hemolyzed blood samples are quickly and easily detected at the time of sampling.
Hemcheck contributes to better care flow, reduced costs and, above all, increased patient safety.
Read moreRead more about the planned deal to acquire IP rights regarding iron succinate treatment of patients with heart failure, from Bio Vitos (SWE)
Read moreHemcheck is listed on Nasdaq First North Growth Market. Are you interested in more financial information about the company?
Read more
Hemcheck's business is based on the Helge product concept. The product concept consists of three different disposable tests, s-Test and bgs-Test for blood samples in blood gas syringes and v-Test for blood samples in test tubes, and a common reader that quickly and easily determines whether the blood sample is hemolyzed or not. An accessory screen can be connected to the reader to enable extraction of quantified free hemoglobin values. The aim is to find hemolyzed blood samples in a few seconds in connection with the blood-sampling or quantifying the amount of free hemoglobin in the blood.
2023-04-26
Read more...2023-04-05
Read more...2023-03-16
Read more...